// company-profile

Provectus Biopharmaceuticals, Inc.

PVCT
ExchangeOTCSectorPharmaceutical PreparationsInc.DEFilings131Insiders7
// api This Provectus Biopharmaceuticals, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 3 insiders purchased shares. Buying was led by Pershing Edward.

// 90-day insight

Over the last 90 days, Provectus Biopharmaceuticals, Inc. insiders bought $0 across 13 transactions with no open-market sales.

  • Most active insider: Pershing Edward with 13 transactions totaling $0.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Provectus Biopharmaceuticals, Inc. as of 2026-03-31

— stable
Total reported AUM
$8,358
QoQ change
Reporting period
2026-03-31
#1
HOME FEDERAL BANK OF TENNESSEE
CIK 1665446
$5,100
100K shares
#2
Wealth Preservation Advisors, LLC
CIK 1968434
$2,677
53K shares
#3
Financial Symmetry Inc
CIK 2004843
$581
10K shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 5, 2026Pershing EdwardPVCT
Option Exercise
0$0.00$0K
Jun 5, 2026Pershing EdwardPVCT
Option Exercise
9,436$0.00$0K
May 28, 2026Pershing EdwardPVCT
Award
0$0.00$0K
May 23, 2026Pershing EdwardPVCT
Option Exercise
0$0.00$0K
May 23, 2026Pershing EdwardPVCT
Option Exercise
32,089$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.